Bristol-Myers Squibb (BMY) – Hot FDA News
-
Bristol-Myers Squibb (BMY) FDA Approves Breyanzi for Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
-
Avidity Biosciences Inc. (RNA) Announces Expansion of Cardiovascular Collaboration with Bristol Myers Squibb (BMY)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to BMY Stock Lookup